Tower Research Capital (TRC)’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,876
Closed -$52K 4865
2019
Q3
$52K Buy
1,876
+1,856
+9,280% +$51.4K ﹤0.01% 1781
2019
Q2
$0 Sell
20
-1,563
-99% ﹤0.01% 4676
2019
Q1
$14K Sell
1,583
-19,030
-92% -$168K ﹤0.01% 2508
2018
Q4
$156K Buy
20,613
+13,083
+174% +$99K 0.01% 777
2018
Q3
$158K Buy
+7,530
New +$158K 0.01% 1112
2018
Q2
Sell
-2,210
Closed -$60K 4328
2018
Q1
$60K Buy
+2,210
New +$60K 0.01% 1581
2017
Q4
Sell
-961
Closed -$23K 4431
2017
Q3
$23K Buy
961
+661
+220% +$15.8K ﹤0.01% 2663
2017
Q2
$7K Buy
+300
New +$7K ﹤0.01% 1854